-
Sort By
-
Newest
-
Newest
-
Oldest
After a three-month run as the most-traded ASX stock on Selfwealth’s platform, Neuron Pharmaceuticals ceded its spot to CBA in June as healthcare, mining and banking stocks jostled for investors’ attention.
Investors and advisers have a tendency to extrapolate recent events into the future, and the last six months have shown how dangerous this can be. For those reviewing and building portfolios as the new financial year begins, five key issues should be front of mind.
The benchmark S&P 500 index is characterised by “narrow, concentrated leadership” by a handful of mega-caps, leading to the “optical illusion” of outsized performance by US equities, says private investment manager Neuberger Berman.
Loosening the reins, ASX 200 higher, banks rally, US recovers on stimulus hopes The ASX 200 (ASX:XJO) staged a stunning recover, finishing the day 1.5% higher leading to a 1.7% improvement for the week. The financial sector, up 3.7%, contributed over half the recovery on its own, ANZ Banking Group Ltd (ASX:ANZ) and National Australia Bank…